As such, in the present study we sought to conduct an in-depth analysis of the role of DYRK2 as a mediator of CRC cell chemoresistance, with a specific focus on its ability to regulate EMT induction through analyses of human tumor tissue samples, CRC cells, and animal model systems. This evidence concerns the gene DYRK2 and colorectal carcinoma.